2011 | 18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
| CANCER |
2015 | 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma
| KOREAN JOURNAL OF RADIOLOGY |
2009 | 20대 이하 간세포암종의 증례 : 20세 미만의 젊은 연령에서 발병한 간세포암종 1예
| Journal of the Korean Liver Cancer Study Group (대한간암연구회지) |
2012 | A case of isolated metastatic hepatocellular carcinoma arising from the pelvic bone
| Korean Journal of Hepatology (대한간학회지) |
2020 | A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea
| CLINICAL AND MOLECULAR HEPATOLOGY |
2012 | Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma | LIVER INTERNATIONAL |
2020 | Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion
| JOURNAL OF HEPATOCELLULAR CARCINOMA |
1999 | Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma | ONCOLOGY REPORTS |
1999 | Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2012 | Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2011 | Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
2014 | Efficacy of concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in locally advanced biliary tract cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2023 | Efficacy of Local Treatment in Lymph Node Metastasis from Hepatocellular Carcinoma | LIVER CANCER |
2010 | Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas? | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2005 | Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
2019 | Noninvasive Biomarker for Predicting Treatment Response to Concurrent Chemoradiotherapy in Patients with Hepatocellular Carcinoma
| Investigative Magnetic Resonance Imaging |
2012 | Pancreatoduodenectomy following neoadjuvant chemoradiation therapy in uncinate process pancreatic cancer. | PANCREAS |
2015 | Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles
| MEDICINE |
2022 | Pattern and clinical significance of lymph node metastasis from hepatocellular carcinoma | JOURNAL OF CLINICAL ONCOLOGY |
2009 | Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy | RADIOLOGY |
2008 | Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.
| CANCER |
2012 | Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer | JOURNAL OF GASTROINTESTINAL SURGERY |
2016 | Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgery | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2019 | Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma | RADIOTHERAPY AND ONCOLOGY |
2024 | Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy
| CANCER RESEARCH AND TREATMENT |
2020 | Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma | JOURNAL OF HEPATOLOGY |
2009 | The Efficacy of Hepatic Resection after Neoadjuvant Transarterial Chemoembolization (TACE) and Radiation Therapy in Hepatocellular Carcinoma Greater Than 5 cm in Size
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2015 | The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement
| MEDICINE |
2017 | Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2021 | Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2010 | Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2008 | Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer
| BRITISH JOURNAL OF CANCER |
2002 | 간문맥 혈전이 동반된 진행성 간세포암에서의 동시 항암 화학-방사선요법
| Korean Journal of Hepatology (대한간학회지) |